Raymond Omollo - Concepedia

Concepedia

Author

Raymond Omollo

Kenya Medical Research Institute

Also Known As

Omollo, Raymond, R. Omollo, Raymond Omollo, Raymond Omollo (156992)

44

Publications

1.5K

Citations

19

H-Index

12

Concepts

All Affiliations

Kenya Medical Research Institute Drugs for Neglected Diseases Initiative London School of Hygiene & Tropical Medicine Addis Ababa University University of Khartoum

RO

About

Raymond Omollo is an author at Kenya Medical Research Institute specializing in post-traumatic stress disorder, medicine, and nursing.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	52
2	Nursing	1	1	52
3	Public Health	1	1	52
4	Social Sciences	1	1	52
5	Global Health	1	1	52

Raymond Omollo

×

24

Publications

1.5K

Citations

19

H-Index

	Year	Citations
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial Ahmed Musa, Eltahir Awad Gasim Khalil, Asrat Hailu, PLoS neglected tropical diseases	2012	168
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial Asrat Hailu, Ahmed Musa, Monique Wasunna, PLoS neglected tropical diseases	2010	144
Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study Ahmed Musa, Brima M. Younis, Ahmed Fadlalla, PLoS neglected tropical diseases	2010	117
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass, The Lancet	2020	106
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial Monique Wasunna, Simon Njenga, Manica Balasegaram, PLoS neglected tropical diseases	2016	103
Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya Rachel Jenkins, Raymond Omollo, John Michael Ong’echa, Malaria Journal	2015	93
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial Eltahir Awad Gasim Khalil, Teklu Weldegebreal, Brima M. Younis, PLoS neglected tropical diseases	2014	91
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia Ermias Diro, Séverine Blesson, Tansy Edwards, PLoS neglected tropical diseases	2019	80
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis, The Lancet Respiratory Medicine	2023	79
Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial Raymond Omollo, Neâl Alexander, Tansy Edwards, Trials	2011	71

Page 1